Topic 1: Basic Information Flashcards

(28 cards)

1
Q

When do you measure baseline characteristics

A

Prior to randomisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When do you compare outcomes from

A

Point of randomisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why do you take baseline characteristics

A

To compare the characteristics of patients in your trial to the characteristics of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does baseline data tell you

A

Who you can generalise the results to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a subgroup effect

A

The effect of certain characteristics that can be used to predict outcomes, given a prognostic model and can therefore be predictors of the size of treatment effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is often looked at in exploratory analysis

A

Subgroup effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common exclusions of patients

A

Learning difficulties, elderly, frail, pregnant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How many primary research questions are there usually

A

One

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does PICOTC stand for

A

Population, Intervention, Control, Outcome, Timing and Context

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is the design and cost of the trial dictated by the primary or secondary research question

A

Primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Secondary Questions are regarded as exploratory, true or false

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the PICOTC framework used for

A

Designing Research questions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples of Secondary Objectives

A

Adverse effects, withdrawals, quality of life, subgroup effects, what baseline factors predict a reduction in score etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens in Phase 1 Trial

A

Look at if drug is harmful to humans, uses small number of participants. Might look at what the maximum tolerated dose is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens in Phase 2 Trials

A

Does it have the potential to be beneficial to patients. Make a stop-go decision.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What happens in Phase 3 Trials

A

A randomised, large, comparative trial. Confirmatory. Confirms effectiveness within a population.

17
Q

What is efficacy

A

Treatment effect produced under ideal conditions

18
Q

What is effectiveness

A

Treatment effect that would be produced in real clinical practice

19
Q

When is an explanatory approach typically taken

A

Earlier stage trials

20
Q

What is the sample like in an explanatory trial

A

Carefully defined patients in a research clinic

21
Q

What is the sample like in a pragmatic trial

A

Reflects variation between treatments that occurs in real clinical practice in order to reduce the chance of over-estimating treatment effect,

22
Q

What are the outcomes in an explanatory trial usually

23
Q

What are the outcomes in a pragmatic trial usually

A

Broad health effects

24
Q

What is the aim of an explanatory trial

A

Further scientific knowledge

25
What is the aim of a pragmatic trial
Inform choice of treatment for a patient
26
Is per-protocol explanatory or pragmatic
Explanatory
27
Is intention to treat explanatory or pragmatic
Pragmatic
28
What does the intention to treatment analysis population consist of
All randomised patients in analysis regardless of anything that happens after randomisation.